reported side effects of adalimumab
upper respiratory tract infection
headache
injection site reaction
skin rash
antibody development
sinusitis
pain at injection site
other side effects
urinary tract infection
abdominal pain
flu-like symptoms
comprehensive list of adverse effects
serious adverse reactions
been serious infections
neurologic events
malignancies
accidental injury
pain in extremity
thorax painrare
pyrexiafrequency
sepsis
pain in thorax
opportunistic infections
tuberculosis
histoplasmosis
abscess
joint infection
wound infection
superficial fungal infections
tuberculosis cases
first months of therapy
pulmonary types
opportunistic infections
histoplasma
aspergillus
nocardia
headache uncommon
confusion
paresthesia
subdural hematoma
tremor
demyelinating disorders
optic neuritis
guillain-barre syndrome
cerebrovascular accident
multiple sclerosis
hypertrophic pachymeningitis
adenoma
merkel cell carcinoma
neuroendocrine carcinoma of the skin
skin papilloma
carcinomas
breast
skin
lymphoma
melanoma
cancer of the white blood cells
hepatosplenic t-cell lymphoma
hstcl
adolescents
young adults
controlled portions of adalimumab trials in patients
active rheumatoid arthritis
psoriatic arthritis
ankylosing spondylitis
malignancies
lymphoma
non-melanoma skin cancer
rate
patient-years among adalimumab-treated patients
rate
patient-years among control patients
median duration of treatment
months for adalimumab-treated patients
months for control-treated patients
controlled portions of adalimumab rheumatoid arthritis trials
rate of non-melanoma skin cancers
patient-years among adalimumab-treated patients
patient-years among control patients
cases of malignancies
patients
receiving tnf blockers
including adalimumab
controls
patients with rheumatoid arthritis
active disease
higher risk for the development of lymphoma
meta-analysis
dose-dependent increased risk of malignancies in patients with rheumatoid arthritis
anti-tnf antibody therapy
positive ana titers
week
patients
placebo
patient
symptoms of new-onset
lupus-like syndrome
discontinuation of adalimumab
low-titer antibodies
adalimumab
treatment
patients
n =-rrb-
antibodies
patients on adalimumab monotherapy
patients on concurrent methotrexate
monotherapy
acr
american college of rheumatology criteria
response
antibody-positive patients
meta-analysis
evidence of an
increased risk of serious infections in patients with rheumatoid arthritis
anti-tnf antibody therapy
flu syndromeuncommon
sarcoidosisfrequency
development of autoantibodies
painuncommon
arthritis
bone disorder
bone fracture
bone necrosis
joint disorder
muscle cramps
myasthenia
pyogenic arthritis
synovitis
tendon disorder
pelvic painrare
rhabdomyolysis
upper
respiratory infection
sinusitis
pneumonia
pharyngitis
nasopharyngitisuncommon
asthma
bronchospasm
dyspnea
lung function
pleural effusion
interstitial lung disease
including
pulmonary fibrosis
pulmonary embolismfrequency
cough
upper respiratory infection
pharyngeal edema
nasal congestion
pulmonary edema
pleural effusion
pleurisy
diarrhea
nausea
abdominal pain
vomiting
stomatitis
mouth ulcerationuncommon
cholecystitis
cholelithiasis
gastroenteritis
gastrointestinal hemorrhage
gastritis
dyspepsia
gastrointestinal disorder
gastrointestinal hemorrhage
rectal hemorrhage
abdominal bloatingrare
esophagitis
intestinal stenosis
colitis
enteritisfrequency
diverticulitis
large bowel perforations
perforations
diverticulitis
appendiceal perforations
appendicitis
pancreatitis
hypercholesterolemia
hyperlipidemiauncommon
dehydration
ketosis
paraproteinemia
alkaline phosphatase
paraproteinemia
urinary tract infection
hematuriauncommon
cystitis
kidney calculus
menstrual disorder
pyelonephritis
injection site pain
injection site reaction
rash common
dermatitis
eczema
pruritus
cellulitis
urticaria
psoriasis
ecchymosis
purpura
erysipelas
cutaneous vasculitis
herpes zosterpostmarketing reports
stevens johnson syndrome
cutaneous vasculitis
erythema multiforme
worsening psoriasis
subtypes
palmoplantar
alopecia
erythema multiforme
panniculitis
cases
worsening
worsening congestive heart failure
chf
new onset chf
tnf blockers
including adalimumab
clinical studies of another tnf blocker
higher rate of serious chf-related adverse events
hypertensionuncommon
arrhythmia
atrial fibrillation
chest pain
coronary artery disorder
heart arrest
hypertensive encephalopathy
myocardial infarct
palpitation
pericardial effusion
pericarditis
syncope
tachycardia
congestive heart failure
peripheral edema
systemic vasculitis
deep vein thrombosisrare
vascular occlusion
aortic stenosis
thrombophlebitis
aortic aneurysm
parathyroid disorder
lymphopenia
agranulocytosis
granulocytopenia
leucopenia
thrombocytopenia
anemia
lymphadenopathy
leucocytosis rare
pancytopenia
polycythemia
idiopathic thrombocytopenia purpura
lymphoma-like reaction
leg thrombosis
hypertriglyceridemia
cataract
frequency
anaphylaxis
liver failure
hepatitisrare
hepatic enzymes
hepatic necrosispostmarketing reports
hepatic failure
frequency
renal pain
renal impairment
body aches
pain
chills
cough
diarrhea
difficulty with breathing
ear congestion
fever
general feeling of discomfort
illness
headache
joint pain
loss of appetite
loss of voice
muscle aches
pains
nausea
pain
tenderness around the eyes
cheekbones
shivering
sneezing
sore throat
runny nose
sweating
tightness of the chest
trouble breathing
trouble sleeping
unusual tiredness
weakness
vomiting
stomach pain
bleeding from the gums
nose
bloating
swelling of the face
arms
hands
lower legs
feet
chest pain
dizziness
eye pain
fainting
irregular heartbeat
general feeling of tiredness
weakness
hoarseness
side pain
difficult urination
rapid weight gain
ringing in the ears
sores
ulcers
white spots on the lips
mouth
tingling of the hands
feet
unusual bleeding
bruising
unusual weight gain
loss
blindness
blistering
peeling
loosening of the skin
blue-yellow color blindness
blurred vision
dark-colored urine
decreased vision
diarrhea
eye pain
general feeling of tiredness
weakness
itching
muscle pain
light-colored stools
red skin lesions
purple center
red, irritated eyes
scaling
crusted skin
stomach pain, continuing
yellow eyes
skin
bleeding
blistering
burning
coldness
discoloration of the skin
feeling of pressure
hives
infection
inflammation
itching
lumps
numbness
pain
rash
redness
scarring
soreness
swelling
tenderness
tingling
ulceration
warmth at the injection site
rash
hair loss
thinning of the hair